DL-Buthionine-(S,R)-sulfoximine (Standard)
DL-Buthionine-(S,R)-sulfoximine (Standard) is the analytical standard of DL-Buthionine-(S,R)-sulfoximine. This product is intended for research and analytical applications. DL-Buthionine-(S,R)-sulfoximine is a potent inhibitor of glutamylcysteine synthetase biosynthesis.
For research use only. We do not sell to patients.
- Purity : 98%
- CAS No.: 5072-26-4
- Formula: C8H18N2O3S
- Molecular Weight:222.31
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Purity & Documentation
-
Help & FAQs
-
HY-106376
DL-Buthionine-(S,R)-sulfoximine -
HY-106376A
L-Buthionine-(S,R)-sulfoximine -
HY-100579
Ferrostatin-1 -
HY-12726
Liproxstatin-1 -
HY-B1645
Ammonium iron(III) citrate -
HY-114481
Imidazole ketone erastin -
HY-103087
FIN56 -
HY-15763
Erastin -
HY-100579R
Ferrostatin-1 (Standard) -
HY-136057
iFSP1 -
HY-129457
FINO2 -
HY-139087
Erastin2
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 5072-26-4
-
Molecular Weight 222.31
-
Formula C8H18N2O3S
-
SMILES
OC(C(N)CCS(CCCC)(=N)=O)=O
-
Synonyms
Buthionine sulfoximine (Standard); BSO (Standard)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Griffith OW, et al. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem. 1979 Aug 25;254(16):7558-60. [Content Brief]
[2]. Vanhoefer U, et al. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Clin Cancer Res. 1996 Dec;2(12):1961-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
DL-Buthionine-(S,R)-sulfoximine (Standard) Related Classifications
HY-106376R Related Classifications
Powered by Bioz